vs

Side-by-side financial comparison of AVISTA CORP (AVA) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

Healthpeak Properties is the larger business by last-quarter revenue ($719.4M vs $533.0M, roughly 1.3× AVISTA CORP). Healthpeak Properties runs the higher net margin — 73.2% vs 13.3%, a 59.9% gap on every dollar of revenue. On growth, Healthpeak Properties posted the faster year-over-year revenue change (3.1% vs 0.0%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $-116.0M). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs -6.5%).

Avista Corporation is an American energy company which generates and transmits electricity and distributes natural gas to residential, commercial, and industrial customers. Approximately 1,550 employees provide electricity, natural gas, and other energy services to 359,000 electric and 320,000 natural gas customers in three western states. The service territory covers 30,000 square miles (78,000 km2) in eastern Washington, northern Idaho, and parts of southern and eastern Oregon, with a popul...

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

AVA vs DOC — Head-to-Head

Bigger by revenue
DOC
DOC
1.3× larger
DOC
$719.4M
$533.0M
AVA
Growing faster (revenue YoY)
DOC
DOC
+3.0% gap
DOC
3.1%
0.0%
AVA
Higher net margin
DOC
DOC
59.9% more per $
DOC
73.2%
13.3%
AVA
More free cash flow
DOC
DOC
$473.0M more FCF
DOC
$357.0M
$-116.0M
AVA
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
-6.5%
AVA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AVA
AVA
DOC
DOC
Revenue
$533.0M
$719.4M
Net Profit
$71.0M
$114.0M
Gross Margin
Operating Margin
21.0%
17.4%
Net Margin
13.3%
73.2%
Revenue YoY
0.0%
3.1%
Net Profit YoY
5.7%
2406.4%
EPS (diluted)
$0.87
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVA
AVA
DOC
DOC
Q4 25
$533.0M
$719.4M
Q3 25
$403.0M
$705.9M
Q2 25
$411.0M
$694.3M
Q1 25
$617.0M
$702.9M
Q4 24
$532.8M
$698.0M
Q3 24
$393.7M
$700.4M
Q2 24
$402.1M
$695.5M
Q1 24
$609.4M
$606.6M
Net Profit
AVA
AVA
DOC
DOC
Q4 25
$71.0M
$114.0M
Q3 25
$29.0M
$-117.1M
Q2 25
$14.0M
$31.7M
Q1 25
$79.0M
$42.8M
Q4 24
$67.2M
$4.5M
Q3 24
$18.5M
$85.9M
Q2 24
$22.9M
$146.0M
Q1 24
$71.5M
$6.7M
Gross Margin
AVA
AVA
DOC
DOC
Q4 25
Q3 25
58.6%
Q2 25
60.2%
Q1 25
61.1%
Q4 24
60.3%
Q3 24
60.0%
Q2 24
60.6%
Q1 24
59.8%
Operating Margin
AVA
AVA
DOC
DOC
Q4 25
21.0%
17.4%
Q3 25
14.9%
9.2%
Q2 25
13.9%
5.7%
Q1 25
20.3%
7.7%
Q4 24
19.1%
-2.2%
Q3 24
12.4%
14.1%
Q2 24
13.5%
22.3%
Q1 24
16.6%
3.7%
Net Margin
AVA
AVA
DOC
DOC
Q4 25
13.3%
73.2%
Q3 25
7.2%
-16.6%
Q2 25
3.4%
4.6%
Q1 25
12.8%
6.1%
Q4 24
12.6%
0.7%
Q3 24
4.7%
12.3%
Q2 24
5.7%
21.0%
Q1 24
11.7%
1.1%
EPS (diluted)
AVA
AVA
DOC
DOC
Q4 25
$0.87
$0.16
Q3 25
$0.36
$-0.17
Q2 25
$0.17
$0.05
Q1 25
$0.98
$0.06
Q4 24
$0.86
$0.02
Q3 24
$0.23
$0.12
Q2 24
$0.29
$0.21
Q1 24
$0.91
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVA
AVA
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$19.0M
$467.5M
Total DebtLower is stronger
$9.8B
Stockholders' EquityBook value
$2.7B
$7.5B
Total Assets
$8.4B
$20.3B
Debt / EquityLower = less leverage
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVA
AVA
DOC
DOC
Q4 25
$19.0M
$467.5M
Q3 25
$44.0M
$91.0M
Q2 25
$9.0M
$89.4M
Q1 25
$17.0M
$70.6M
Q4 24
$30.0M
$119.8M
Q3 24
$9.1M
$180.4M
Q2 24
$14.6M
$106.9M
Q1 24
$12.3M
$101.8M
Total Debt
AVA
AVA
DOC
DOC
Q4 25
$9.8B
Q3 25
$9.1B
Q2 25
$9.0B
Q1 25
$8.9B
Q4 24
$8.7B
Q3 24
$8.6B
Q2 24
$8.6B
Q1 24
$8.8B
Stockholders' Equity
AVA
AVA
DOC
DOC
Q4 25
$2.7B
$7.5B
Q3 25
$2.6B
$7.6B
Q2 25
$2.6B
$7.9B
Q1 25
$2.6B
$8.2B
Q4 24
$2.6B
$8.4B
Q3 24
$2.5B
$8.6B
Q2 24
$2.5B
$8.8B
Q1 24
$2.5B
$8.9B
Total Assets
AVA
AVA
DOC
DOC
Q4 25
$8.4B
$20.3B
Q3 25
$8.2B
$19.6B
Q2 25
$8.1B
$19.8B
Q1 25
$8.0B
$19.8B
Q4 24
$7.9B
$19.9B
Q3 24
$7.8B
$20.0B
Q2 24
$7.7B
$20.2B
Q1 24
$7.6B
$20.5B
Debt / Equity
AVA
AVA
DOC
DOC
Q4 25
1.31×
Q3 25
1.20×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.04×
Q3 24
1.00×
Q2 24
0.98×
Q1 24
0.99×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVA
AVA
DOC
DOC
Operating Cash FlowLast quarter
$75.0M
$1.3B
Free Cash FlowOCF − Capex
$-116.0M
$357.0M
FCF MarginFCF / Revenue
-21.8%
49.6%
Capex IntensityCapex / Revenue
35.8%
124.4%
Cash ConversionOCF / Net Profit
1.06×
10.99×
TTM Free Cash FlowTrailing 4 quarters
$-101.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVA
AVA
DOC
DOC
Q4 25
$75.0M
$1.3B
Q3 25
$170.0M
$315.0M
Q2 25
$40.0M
$363.5M
Q1 25
$184.0M
$279.4M
Q4 24
$89.8M
$1.1B
Q3 24
$127.2M
$318.2M
Q2 24
$126.8M
$316.2M
Q1 24
$190.1M
$152.6M
Free Cash Flow
AVA
AVA
DOC
DOC
Q4 25
$-116.0M
$357.0M
Q3 25
$37.0M
Q2 25
$-103.0M
Q1 25
$81.0M
Q4 24
$-37.8M
$333.7M
Q3 24
$-27.0M
Q2 24
$-5.7M
Q1 24
$71.4M
FCF Margin
AVA
AVA
DOC
DOC
Q4 25
-21.8%
49.6%
Q3 25
9.2%
Q2 25
-25.1%
Q1 25
13.1%
Q4 24
-7.1%
47.8%
Q3 24
-6.9%
Q2 24
-1.4%
Q1 24
11.7%
Capex Intensity
AVA
AVA
DOC
DOC
Q4 25
35.8%
124.4%
Q3 25
33.0%
Q2 25
34.8%
Q1 25
16.7%
Q4 24
23.9%
105.6%
Q3 24
39.2%
Q2 24
33.0%
Q1 24
19.5%
Cash Conversion
AVA
AVA
DOC
DOC
Q4 25
1.06×
10.99×
Q3 25
5.86×
Q2 25
2.86×
11.48×
Q1 25
2.33×
6.52×
Q4 24
1.34×
235.43×
Q3 24
6.88×
3.71×
Q2 24
5.55×
2.17×
Q1 24
2.66×
22.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons